wire - news in brief


Category


Years
2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008

Last News


Results 101 - 150 of 321.

Administration/Government - Careers/Employment
17.05.2017
Stable demand for SNSF funding
Stable demand for SNSF funding
In 2016, the Swiss National Science Foundation (SNSF) supported around 3200 research projects involving more than 14,000 researchers from universities, universities of applied sciences, universities
Medicine/Pharmacology
17.05.2017
Novartis Foundation and partners launch initiative to tackle hypertension and its root causes in low-income urban communities
Better Hearts Better Cities is a Novartis Foundation initiative to improve cardiovascular health in low-income urban communities by addressing the prevention, management and control of hypertension.
Earth Sciences
16.05.2017
Reconstructing a lake's history by simple means
Reconstructing a lake’s history by simple means
Media releases, information for representatives of the media Media Relations (E) The sediments of Lake Van in Eastern Anatolia (Turkey) are a valuable climate archive.
Physics/Materials Science
16.05.2017
Persistent and curious
Persistent and curious
As Professor of Particle Physics, Felicitas Pauss played a key role in the discovery of the Higgs boson.
Physics/Materials Science - Chemistry
15.05.2017
The future's bright, the future's OLED
The future’s bright, the future’s OLED
Organic light-emitting diodes (OLEDs) will soon show our world in a new light: the days of small light sources are numbered; in future, entire walls, ceilings, façades and car exteriors will light up our lives.
Physics/Materials Science - Chemistry
12.05.2017
Hydrogen Bonds Directly Detected for the First Time
Hydrogen Bonds Directly Detected for the First Time
For the first time, scientists have succeeded in studying the strength of hydrogen bonds in a single molecule using an atomic force microscope. Researchers from the University of Basel's Swiss Nanoscience Institute network have reported the results Advances. Hydrogen is the most common element in the universe and is an integral part of almost all organic compounds.
Physics/Materials Science - Chemistry
11.05.2017
Event
11.05.2017
Social Sciences - Sport Sciences
11.05.2017
Better a ‘No’ Than No Answer at All
After experiencing social exclusion, a minimum of attention suffices to reduce individuals' negative emotions. Even rejection or unkind comments are better for well-being than being ignored by other people. This finding has important implications for the treatment of applicants during selection processes, report psychologists from the University of Basel and Purdue University in the Personality and Social Psychology Bulletin.
Medicine/Pharmacology
11.05.2017
Roche to present new data on personalised medicines and cancer immunotherapies at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting
Roche to present new data on personalised medicines and cancer immunotherapies at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting 20 Roche medicines are included in more than 190
Life Sciences - Medicine/Pharmacology
10.05.2017
Two major projects drive genetics research forward at Campus Biotech
Two major projects drive genetics research forward at Campus Biotech
Good news for the fields of genetic research and gene therapy: two major projects based at Campus Biotech, EPFL's outpost in Geneva, were announced simultaneously today.
Medicine/Pharmacology - Administration/Government
10.05.2017
Roche provides update on phase III study of TECENTRIQ (atezolizumab) in people with previously treated advanced bladder cancer
Roche provides update on phase III study of TECENTRIQ (atezolizumab) in people with previously treated advanced bladder cancer IMvigor211 study did not meet its primary endpoint of overall survival (
Civil Engineering/Traffic Engineering
09.05.2017
EPFL to participate in a concrete canoe race for the first time
This semester, eight civil engineering students at EPFL will take part in a slightly off-the-wall challenge: they are building a reinforced-concrete canoe that they will then race in a university regatta in Germany.
Chemistry - Physics/Materials Science
08.05.2017
Quartz powder for the battery of the future
Quartz powder for the battery of the future
The invisible becomes visible within lithium-sulphur batteries Materials researchers of the Paul Scherrer Institute PSI in Switzerland have, in collaboration with the Université Grenoble Alpes (France), developed a method that could enable a breakthrough for the lithium-sulphur battery. In theory, lithium-sulphur batteries can deliver considerably more energy than today's conventional lithium-ion batteries, but current prototypes show a distinct loss of capacity after just a few charging cycles.
Environment/Sustainable Development - Careers/Employment
08.05.2017
Immersive virtual-reality creation software for everyone
Immersive virtual-reality creation software for everyone
Imverse, an EPFL spinoff, has developed a software that lets users convert 360-degree images from 2D into 3D and both manipulate and create virtual-reality content in real time with the help of virtual-reality glasses.
Life Sciences - Environment/Sustainable Development
08.05.2017
What silver fir aDNA can tell us about Neolithic forests
What silver fir aDNA can tell us about Neolithic forests
Media releases, information for representatives of the media Media Relations (E) A new technique makes it possible to cost-effectively analyse genetic material from fossil plant and animal remains. Researchers from the Swiss Federal Institute for Forest, Snow and Landscape Research WSL and the universities of Lausanne and Bern have used this technique to examine the DNA of silver fir needles found in lake sediment in Ticino.
Environment/Sustainable Development - Careers/Employment
08.05.2017
Immersive virtual-reality software for everyone
Immersive virtual-reality software for everyone
Imverse, an EPFL spinoff, has developed software that lets users convert 360-degree images from 2D into 3D and both manipulate and create virtual-reality content in real time with the help of virtual-reality glasses.
Medicine/Pharmacology
08.05.2017
Women Perform Worse in CPR
Women Perform Worse in CPR
Does it matter whether a man or a woman carries out CPR? Researchers at the University of Basel and University Hospital Basel have shown that female resuscitation teams performed cardiopulmonary resuscitation less efficiently than their male counterparts. The study suggests that there is a need for action in the training of young female physicians.
Event
05.05.2017
Construction start for NEST unit 'dfab
Construction start for NEST unit ’dfab
On May 2, at the ground-breaking ceremony for the NEST unit ‘dfab house', the project team, consisting of the National Center of Competence in Research (NCCR) ‘Digital Fabrication', ETH Z
Computer Science/Telecom - Architecture
05.05.2017
How does trust work on the internet?
How does trust work on the internet?
A secure and reliable internet generates trust. Just how the internet creates trust is a matter for debate between ETH computer scientists and social scientists - for example, in a public session on 9 May 2017.
Medicine/Pharmacology - Life Sciences
04.05.2017
Comprehensive Atlas of Immune Cells in Renal Cancer
Comprehensive Atlas of Immune Cells in Renal Cancer
Renal cell carcinoma is one of the most frequent and deadly urogenital cancers. Even if the tumors are treated, they ultimately end in metastasis in about half of the patients. 90 percent of these patients die within five years. Thanks to new kinds of immunotherapies, the outlook of this patient group has improved, but the treatment only works for a minority of patients.
Life Sciences - Physics/Materials Science
04.05.2017
A magic hood for artificial heart pumps
A magic hood for artificial heart pumps
Ten million people in Europe alone suffer from cardiac insufficiency, or a weak heart. One day, many of them may require a heart transplant.
Physics/Materials Science - Medicine/Pharmacology
04.05.2017
Sustainable biomedical textiles for the
Sustainable biomedical textiles for the
The textile and clothing industry has a long history in Switzerland. In order to remain competitive in the international market, the industry relies on innovations.
Event
04.05.2017
Photography: An unusual and surprising picture of science
Photography: An unusual and surprising picture of science
The winning entries from the first SNSF Scientific Image Competition offer a view of science that is aesthetic, nuanced and complex.
Medicine/Pharmacology - Business/Economics
04.05.2017
Novartis exercises exclusive option agreement with Conatus for the treatment of NASH
Exclusive license for emricasan supports rapidly growing development portfolio in chronic liver diseases, including NASH   Conatus has initiated the Phase IIb ENCORE-LF clinical trial with emricasan in NASH.
Chemistry - Physics/Materials Science
04.05.2017
Making a valuable resource usable with water
Making a valuable resource usable with water
New reaction for converting methane into methanol In oil extraction sites, gaseous methane is simply burned, even though it could actually be a useful precursor material for fuels and products of the chemical industry. One way to make methane usable is to convert it to methanol. Being liquid, methanol is easier to transport than methane, and it can be used both as fuel and as raw material for the chemical industry.
Physics/Materials Science - Computer Science/Telecom
03.05.2017
Materials in a digitalized world
We hope to lead you on a gripping journey through the world of research and innovation; you may be surprised at how broad the term «applied research» is defined at Empa.
Arts and Design
03.05.2017
Photographs of a pioneer's adventures
Photographs of a pioneer’s adventures
Walter Mittelholzer is one of the most sought-after photographers in the ETH Bibliothek's Image Archive.
Architecture
03.05.2017
Preserving alpine architecture through drawings
Preserving alpine architecture through drawings
A new publication, a panel discussion and projects by EPFL students consider the future of alpine villages and their often-abandoned architectural heritage - particularly their emblematic granaries.
Chemistry - Physics/Materials Science
02.05.2017
Sodium and magnesium to replace lithium
Sodium and magnesium to replace lithium
Scientists supported by the SNSF have produced novel electrolytes for rechargeable sodium and magnesium batteries. The research group's objective was to develop alternatives to lithium-ion technology. A project supported by the Swiss National Science Foundation (SNSF) aims to find new materials which can be used in rechargeable batteries and eventually provide alternatives to the current lithium batteries.
Earth Sciences - Astronomy
02.05.2017
Two's company when it comes to 3D mapping
Two's company when it comes to 3D mapping
EPFL researchers have developed the terrestrial and aerial components of a European spatial and urban mapping project.
History/Archeology
02.05.2017
The stories of survivors and life after the Holocaust
The stories of survivors and life after the Holocaust
The «Last Swiss Holocaust Survivors» exhibition, which opens today at the ETH Zurich Archives of Contemporary History, tells the stories of how fourteen eyewitnesses survived the Holocaust and then went on with their lives.
Environment/Sustainable Development
01.05.2017
Scientastic festival held in Valais for the first time
Scientastic festival held in Valais for the first time
EPFL's Valais Wallis campus in Sion hosted the school's third annual science festival this past weekend, drawing a large public turnout.
Medicine/Pharmacology - Life Sciences
28.04.2017
Novartis receives FDA approval for Rydapt in newly diagnosed FLT3-mutated acute myeloid leukemia (AML) and three types of systemic mastocytosis (SM)
Novartis receives FDA approval for Rydapt in newly diagnosed FLT3-mutated acute myeloid leukemia (AML) and three types of systemic mastocytosis (SM) Approval in newly diagnosed FLT3-mutated AML repre
Medicine/Pharmacology - Physics/Materials Science
27.04.2017
Getting a Handle on Safety
Getting a Handle on Safety
Protons can accurately target and eliminate cancerous cells by erasing their genetic substance DNA. Doctors at the Centre for Proton Therapy at the Paul Scherrer Institute PSI use protons to treat patients with deep-seated tumours or ocular cancer.
Careers/Employment
27.04.2017
Environment/Sustainable Development - Business/Economics
27.04.2017
Publication of Annual and Sustainability Reports
Publication of Annual and Sustainability Reports
The ETH Zurich 2016 Annual Report provides an overview of the most important achievements, developments and events at the University over the past year, and is published alongside the 2015/2016 Sustainability Report.
Careers/Employment - Mechanical Engineering/Mechanics
26.04.2017
The multitasker
The multitasker
Developing new things together and effecting change - that's what gets Moritz Mussgnug out of bed in the morning.
Medicine/Pharmacology - Business/Economics
26.04.2017
Alcon announces EU launch of CyPass Micro-Stent, a micro invasive glaucoma surgical device, to lower intraocular pressure (IOP) in patients with primary open-angle glaucoma
Alcon announces EU launch of CyPass Micro-Stent, a micro invasive glaucoma surgical device, to lower intraocular pressure (IOP) in patients with primary open-angle glaucoma Now available in the UK, G
Life Sciences - Medicine/Pharmacology
26.04.2017
Link Discovered between Immune System, Brain Structure and Memory
Link Discovered between Immune System, Brain Structure and Memory
In two independent studies, scientists at the University of Basel have demonstrated that both the structure of the brain and several memory functions are linked to immune system genes. The scientific journals Nature Communications and Nature Human Behaviour have published the results of the research.
Business/Economics - Medicine/Pharmacology
25.04.2017
Novartis delivered sales growth across all divisions (cc1) as growth drivers, including Cosentyx and Entresto, more than offset generic erosion; innovation momentum continued
Novartis delivered sales growth across all divisions (cc1) as growth drivers, including Cosentyx and Entresto, more than offset generic erosion; innovation momentum continued Net sales grew 2% (cc, -1
Social Sciences
24.04.2017
Productive humanities and social sciences networks
Productive humanities and social sciences networks
The 5 National Centres of Competence in Research (NCCRs) in the humanities and social sciences have achieved their goals: they have facilitated productive research and created professorships, chairs, institutes and partnerships.
Medicine/Pharmacology - Life Sciences
24.04.2017
Novartis real-world data at AAN confirms benefit of Gilenya on four key measures of disease activity in relapsing MS
Over 16 months, more than 75% of patients on Gilenya had either no relapses, no new or enlarged MRI lesions or no disability progression; around 58% showed brain shrinkage levels broadly within the range expected for people without MS   Approximately 60% of patients achieved NEDA-3 (no relapses, no MRI lesions and no disability progression combined) and 38% achieved NEDA-4 (NEDA-3 plus no brain shrinkage), further supporting findings from clinic
Medicine/Pharmacology - Life Sciences
24.04.2017
Novartis expands global collaboration with Amgen to commercialize first-in-class AMG 334 (erenumab) program in migraine prevention in the US and Canada
Novartis expands global collaboration with Amgen to commercialize first-in-class AMG 334 (erenumab) program in migraine prevention in the US and Canada Novartis and Amgen to co-commercialize AMG 334
Medicine/Pharmacology - Life Sciences
21.04.2017
Sandoz proposed biosimilars rituximab and etanercept recommended for approval in Europe*
Sandoz receives positive CHMP opinions for biosimilars rituximab and etanercept to treat immunological diseases.
Medicine/Pharmacology
21.04.2017
EPFL non-profit iM4TB awarded $2.45m for anti-TB drug clinical trials
EPFL non-profit iM4TB awarded $2.45m for anti-TB drug clinical trials
The Bill & Melinda Gates foundation has awarded EPFL-based non-profit iM4TB $2.45 million to take their innovative anti-tuberculosis drug PBTZ169 into clinical trials.
Medicine/Pharmacology - Administration/Government
20.04.2017
NIH study in NEJM shows Novartis drug eltrombopag as first-line therapy with standard treatment improves responses in severe aplastic anemia
NIH study in NEJM shows Novartis drug eltrombopag as first-line therapy with standard treatment improves responses in severe aplastic anemia NIH study found 58% of patients with treatment-naïve severe aplastic anemia (SAA) achieved a complete response when eltrombopag was given at the initiation of and concurrently with standard immunosuppressive therapy   The historical complete response rate was 10% for untreated patients with SAA on immunosup